Nature Medicine Commission launch highlights closing day of Texas Brain Economy Summit

Global leaders in neuroscience, public policy, economics, and healthcare announced the launch of the Nature Medicine Commission on Brain Health for Economic Resilience on Wednesday, June 10, during the second and closing day of the Texas Brain Economy Summit at TMC3 in the Texas Medical Center in Houston.

The announcement marked a major milestone for the growing global movement focused on brain health, healthy aging, and economic competitiveness, bringing together more than 500 attendees from around the world to explore how cognitive well-being influences workforce productivity, innovation, and long-term societal resilience.

The commission - which will convene experts from leading institutions across North America, Europe, Latin America, Africa, Asia, and Australia - will operate over the next two years and publish its findings in Nature Medicine. Its work will focus on developing and validating measurement frameworks for brain health and brain capital, strengthening the scientific evidence base, and creating implementation strategies that governments, industries, and organizations can adopt worldwide.

"The brain economy movement has generated tremendous energy, enthusiasm, and inspiration around the world," said Harris Eyre, PhD, lead of the Global Brain Economy Initiative, a presidential fellow at The University of Texas Medical Branch, and a senior fellow at Rice University's Baker Institute for Public Policy. "But for a movement to endure, it must be grounded in rigorous science. That's why we are launching this Nature Medicine Commission, to provide the scientific foundation that can help sustain and accelerate this work for years to come."

A central focus of the commission will be evaluating and strengthening emerging brain capital and brain health indexes through a rigorous peer-review process while developing practical strategies that countries around the world can use to improve population brain health and economic resilience.

Dr. Jochen Reiser, president of UTMB and CEO of the UTMB Health System, said the commission represents an important step in ensuring that the momentum surrounding brain health remains firmly rooted in evidence-based science.

"Anyone familiar with scientific publishing understands that earning the support of a leading journal such as Nature Medicine is no small accomplishment," Reiser said. "The launch of this commission reflects the growing credibility of this movement and the recognition that brain health deserves serious scientific and global attention."

Reiser emphasized that scientific rigor must remain central as the field continues to evolve.

"As this movement continues to grow, we must ensure that the science keeps pace with the enthusiasm," Reiser said. "This commission serves as an important reminder that everything we do must be rooted in evidence and guided by rigorous research."

The initiative also seeks to elevate the importance of neuroscience research among policymakers, philanthropic organizations, and industry leaders while helping identify new opportunities for investment and collaboration.

"Our goal is to move this conversation all the way to the level of heads of state," Eyre said. "By combining strong science with actionable policy recommendations, we can help governments understand that investing in brain health is not only a health priority - it is an economic imperative."

The commission announcement capped a day that featured discussions on health systems transformation, workforce development, therapeutic innovation, and public policy. Among the keynote speakers was Texas Lt. Gov. Dan Patrick, who reflected on the state's recent voter-approved investment in dementia research through the Dementia Prevention and Research Institute of Texas (DPRIT).

Patrick described the initiative as a once-in-a-generation opportunity to accelerate discoveries related to Alzheimer's disease and other forms of dementia while positioning Texas as a global leader in brain research.

"When I came into session, I said we have an opportunity in Texas to do big things," Patrick told attendees. "Texas is the greatest place on Earth, and we've been given the opportunity to tackle one of the most important health challenges facing families today."

Patrick noted that nearly 460,000 Texans are currently living with Alzheimer's disease and emphasized the far-reaching impact on caregivers and families across the state.

"Alzheimer's impacts millions of Texans in different ways," Patrick said. "The families are the ones who live with this disease for a long time, and they're the caregivers."

He also highlighted the state's commitment to long-term research funding, noting that sustained investment is essential to attracting top scientific talent and accelerating breakthroughs.

"It's now in your hands," Patrick told researchers and clinicians in attendance. "How are you going to take the resources available and put them to use so that we can find better care, better prevention and, one day, hopefully a cure?"

Throughout the day, summit attendees explored how health systems, governments, employers, and research institutions can work together to advance brain health and support economic growth. Reiser participated in a panel discussion titled "Systems Transformation for the Brain Economy," which examined how organizations can integrate brain health into health care delivery, workforce development, and public policy strategies.

Giulio Taglialatela, PhD, director of the Moody Brain Health Institute at UTMB, joined experts from academia and industry for a panel titled "Industrializing Brain Therapeutics," which focused on accelerating the development, commercialization, and delivery of next-generation treatments for neurological and neurodegenerative diseases.

Organizers said the summit's second day, organized by Office of Innovation at UTMB, led by Vineet Gupta, PhD, reflected the growing international momentum around brain health as both a public health priority and an economic imperative.